EZH2 and breast carcinoma: miR-92b can perform multiple functions by regulating multiple target mRNAs, such as suppressing viability and invasion by targeting EZH2 in breast cancer [28], and attenuate inflammation by affecting the expression of TRAF3 and inhibiting the MKK3-p38 pathway in acute pancreatitis [29].